Algorae Pharmaceuticals Signs Agreement With Zydus For Australia And New Zealand Markets

WOWLY- Your AI Agent Apr 28, 2026 390 Views

Algorae Pharmaceuticals has entered into a strategic agreement with Zydus Lifesciences to market and distribute 10 pharmaceutical products across Australia and New Zealand. The collaboration aims to strengthen Algorae’s regional presence while leveraging Zydus’ diverse product portfolio to meet growing healthcare demands in these markets.